Catalent, Inc. Announces Launch of Secondary Public Offering of Common Stock
02 März 2015 - 1:00PM
Business Wire
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global
provider of advanced delivery technologies and development
solutions for drugs, biologics and consumer health products, today
announced the launch of a secondary public offering of its common
stock. Certain stockholders of Catalent (the “Selling
Stockholders”) are offering for sale to the public 20 million
shares of Catalent’s common stock owned by them. The Selling
Stockholders will grant to the underwriters of the secondary
offering an option to purchase up to 3 million additional shares of
common stock. Catalent is not offering any stock in this
transaction and will not receive any proceeds from the sale of the
shares by the Selling Stockholders.
Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs
& Co., Jefferies and Deutsche Bank Securities are acting as
joint bookrunning managers for the offering. Blackstone Capital
Markets, Piper Jaffray, Raymond James, Wells Fargo Securities,
William Blair and Evercore ISI are acting as co-managers for the
offering.
A registration statement relating to the Catalent shares being
offered by the Selling Stockholders has been filed with the U.S.
Securities and Exchange Commission (“SEC”), but has not yet become
effective. The Selling Stockholders’ shares may not be sold, nor
may offers to buy be accepted, prior to the time the registration
statement becomes effective.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy the securities described above, nor
shall there be any sale of such shares of common stock in any state
or jurisdiction in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
The offering of the shares of common stock will be made only by
means of a prospectus, copies of which may be obtained from Morgan
Stanley & Co. LLC, Attention: Prospectus Department., 180
Varick Street, 2nd Floor, New York, NY 10014; or from J.P. Morgan,
Attention: Prospectus Department c/o Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, NY, 11717 or via
telephone: +1 (866) 803-9204. The registration statement is
available on the SEC’s website at www.sec.gov under the registrant’s name.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. You can identify these forward-looking statements by the
use of words such as “outlook,” “believes,” “expects,” “potential,”
“continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,”
“predicts,” “intends,” “plans,” “estimates,” “anticipates” or the
negative version of these words or other comparable words and
include all discussions of the contemplated secondary public
offering. Such forward-looking statements are subject to various
risks and uncertainties, including (a) any decision by the Selling
Stockholders or the underwriters not to proceed with the proposed
secondary offering, (b) market conditions making the secondary
offering unattractive to potential purchasers of the offered shares
of common stock, and (c) those risks and uncertainties described
under the section entitled “Part I —Item 1A. Risk Factors” of
Catalent’s Annual Report on Form 10-K for the fiscal year ended
June 30, 2014, filed with the SEC, as such factors may be updated
from time to time in Catalent’s periodic filings with the SEC,
which are accessible on the SEC’s website at www.sec.gov.
Accordingly, there are or will be important factors that could
cause actual outcomes or results to differ materially from those
indicated in these statements. These factors should not be
construed as exhaustive and should be read in conjunction with the
other cautionary statements that are included in Catalent’s filings
with the SEC. Catalent undertakes no obligation to publicly update
or review any forward-looking statement, whether as a result of new
information, future developments or otherwise, except as required
by law.
Investor Contact:Catalent, Inc.Thomas CastellanoorBertner
Advisors, LLCJeremy Feffer, 732-537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024